Ajax Therapeutics Overview
- Year Founded
-
2019
- Status
-
Acquired/Merged
- Employees
-
9
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$2.3B
Ajax Therapeutics General Information
Description
Developer of targeted therapy drugs designed for the treatment of hematologic cancers. The company utilizes molecular genetics and biology to develop new classes of therapies that are selective for specific drug targets, while aiming to minimize interactions with related proteins, enabling healthcare providers to access effective and precise treatment options for patients with blood cancers.
Contact Information
Website
www.ajaxtherapeutics.com(Operating Subsidiary)
Corporate Office
- 275 Madison Avenue
- 39th Floor
- New York, NY 10016
- United States
Corporate Office
- 275 Madison Avenue
- 39th Floor
- New York, NY 10016
- United States
Ajax Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 13-Jun-2026 | $2.3B | Completed | Clinical Trials - Phase 1 | ||
| 4. Secondary Transaction - Private | Completed | Clinical Trials - Phase 1 | ||||
| 3. Later Stage VC (Series C) | 13-May-2024 | Completed | Clinical Trials - Phase 1 | |||
| 2. Early Stage VC (Series B) | 01-Jun-2021 | $40M | $48M | Completed | Clinical Trials - Phase 1 | |
| 1. Early Stage VC (Series A) | 28-Jun-2019 | $8M | $8M | Completed | Clinical Trials - Phase 1 |
Ajax Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 8,000,000 | $0.000100 | $1 | $1 | 1x | $1 | 8.8% |
Ajax Therapeutics Comparisons
Industry
Financing
Details
Ajax Therapeutics Competitors (3)
One of Ajax Therapeutics’s 3 competitors is CTI BioPharma, a Formerly VC-backed company based in Seattle, WA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CTI BioPharma | Formerly VC-backed | Seattle, WA | ||||
| Vor Biopharma | Formerly VC-backed | Boston, MA | ||||
| Cornerstone Pharmaceuticals | Venture Capital-Backed | Cranbury, NJ |
Ajax Therapeutics Patents
Ajax Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260078131-A1 | Pyrrolo-pyridazine inhibitors of jak2 | Pending | 27-Jun-2025 | ||
| WO-2026078542-A1 | Janus kinase 2 degraders | Pending | 07-Oct-2024 | ||
| WO-2026055409-A1 | Pyrrolo-pyridazine inhibitors of jak2 | Pending | 06-Sep-2024 | ||
| WO-2025245175-A1 | Macrocyclic heteroaromatic inhibitors of jak2 | Pending | 22-May-2024 | ||
| AU-2025265863-A1 | 5,6 bicyclic heteroaromatic inhibitors of jak2 | Pending | 29-Apr-2024 | A61P35/00 |
Ajax Therapeutics Signals
Ajax Therapeutics Former Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Boxer Capital | Corporate Venture Capital | Minority | ||
| EcoR1 Capital | Venture Capital | Minority | ||
| Goldman Sachs Asset Management | Asset Manager | Minority | ||
| Inning One Ventures | Venture Capital | Minority | ||
| Memorial Sloan Kettering Cancer Center | Accelerator/Incubator | Minority |
Ajax Therapeutics FAQs
-
When was Ajax Therapeutics founded?
Ajax Therapeutics was founded in 2019.
-
Where is Ajax Therapeutics headquartered?
Ajax Therapeutics is headquartered in New York, NY.
-
What is the size of Ajax Therapeutics?
Ajax Therapeutics has 9 total employees.
-
What industry is Ajax Therapeutics in?
Ajax Therapeutics’s primary industry is Drug Discovery.
-
Is Ajax Therapeutics a private or public company?
Ajax Therapeutics is a Private company.
-
What is the current valuation of Ajax Therapeutics?
The current valuation of Ajax Therapeutics is .
-
What is Ajax Therapeutics’s current revenue?
The current revenue for Ajax Therapeutics is .
-
How much funding has Ajax Therapeutics raised over time?
Ajax Therapeutics has raised $143M.
-
Who are Ajax Therapeutics’s investors?
Boxer Capital, EcoR1 Capital, Goldman Sachs Asset Management, Inning One Ventures, and Memorial Sloan Kettering Cancer Center are 5 of 11 investors who have invested in Ajax Therapeutics.
-
Who are Ajax Therapeutics’s competitors?
CTI BioPharma, Vor Biopharma, and Cornerstone Pharmaceuticals are competitors of Ajax Therapeutics.
-
When was Ajax Therapeutics acquired?
Ajax Therapeutics was acquired on 13-Jun-2026.
-
Who acquired Ajax Therapeutics?
Ajax Therapeutics was acquired by Lilly USA.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process